For instance, researchers have used covalently coupled epidermal growth factor receptor (EGFR)-targeting peptides or anti-EGFR nanobodies, causing them to accumulate in EGFR-positive cancer cells for targeted therapy [13]. The gene discussed is EGFR; the disease is cancer.